Dabrafenib Alters MDSC Differentiation and Function by Activation of GCN2.

导出 LinkOut

翻译打印收藏纠错

作者： M Teresa,Ciudad ^[1] ; Rene,Quevedo ^[1] ; Sara,Lamorte ^[1] ; Robbie,Jin ^[1] ; Nadine,Nzirorera ^[1] ; Marianne,Koritzinsky ^[2] ; Tracy L,McGaha ^[1]

作者单位： Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.;Department of Immunology, University of Toronto, Toronto, Canada. ^[1] Princess Margaret Cancer Center, University Health Network, Toronto, Canada.;Institute of Medical Science, University of Toronto, Toronto, Canada.;Department of Radiation Oncology, University of Toronto, Toronto, Canada.;Department of Medical Biophysics, University of Toronto, Toronto, Canada. ^[2]

主题词动物(Animals);小鼠(Mice);细胞系, 肿瘤(Cell Line, Tumor);原癌基因蛋白质B-raf(Proto-Oncogene Proteins B-raf);DNA结合蛋白质类(DNA-Binding Proteins);转录因子(Transcription Factors);咪唑类(Imidazoles);肟类(Oximes)

DOI 10.1158/2767-9764.CRC-23-0376

PMID 38421883

发布时间 2025-01-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer research communications

2024年4卷3期

765-784页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Dabrafenib Alters MDSC Differentiation and Function by Activation of GCN2.

Cancer research communications

相似文献

Cancer research communications

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Dabrafenib Alters MDSC Differentiation and Function by Activation of GCN2.

Cancer research communications

相似文献

Cancer research communications

相关期刊

检索历史清除